Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 28;24(2):284.
doi: 10.3892/ol.2022.13404. eCollection 2022 Aug.

Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma

Affiliations
Review

Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma

Huan Chen et al. Oncol Lett. .

Abstract

Metastasis is one of the major reasons for patient mortality in hepatocellular carcinoma (HCC), and the progression of HCC to a metastatic state depends on the local microenvironment. Hypoxia is a key condition affecting the microenvironment of HCC. Currently, various studies have shown that the expression of hypoxia-ainducible factor-1α (HIF-1α) is associated with the invasion and metastasis of HCC. High expression of HIF-1α often leads to poor prognosis in patients with HCC. In this review, the molecular structure of HIF-1α is described, and the expression pattern of HIF-1α in HCC under hypoxia, which is associated with metastasis and poor prognosis in HCC, is explained. The molecular mechanisms of HIF-1α function and the metastasis of HCC are further discussed. The modulation of HIF-1α can reduce sorafenib resistance and improve the prognosis of patients after TACE. Therefore, HIF-1α may be a critical target for inhibiting HCC metastasis in the future.

Keywords: HIF-1α; hepatocellular carcinoma; hypoxia; hypoxia-inducible factor-1α; tumor metastasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Structure and synthetic pathway of HIF-1α. (A) Structure of HIF-1α. (B) (a) High expression of HDAC5 in hepatocellular carcinoma leads to silencing of HIPK2, which in turn induces the upregulation of HIF-1α. (b) M2-phenotype TAMs release IL-1β in the presence of persistent hypoxia and inflammation, which promotes HIF-1α synthesis. (c) DAAM can induce HIF-1α by reducing the expression of VHL in hepatoma cells. (d) Activated HSCs promote the upregulation of TGM2 in HCC cells through inflammatory signals, which can cause VHL depletion and lead to HIF-1α accumulation. TAMs, tumor-associated macrophages; IL-1β, interleukin-1β; HDAC5, histone deacetylase5; HIF-1α, hypoxia-inducible factor-1α; HIPK2, recombinant homeodomain interacting protein kinase 2; HSCs, hepatic stellate cells; VHL, Von Hippel-Lindau; TGM2, transglutaminase 2; DAAM, Dishevelled-associated activator of morphogenesis.

Similar articles

Cited by

References

    1. Liu X, Zhang X, Peng Z, Li C, Wang Z, Wang C, Deng Z, Wu B, Cui Y, Wang Z, et al. Deubiquitylase OTUD6B Governs pVHL stability in an enzyme-independent manner and suppresses hepatocellular carcinoma metastasis. Adv Sci (Weinh) 2020;7:1902040. doi: 10.1002/advs.201902040. - DOI - PMC - PubMed
    1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. doi: 10.1016/S0140-6736(18)30010-2. - DOI - PubMed
    1. Wang X, Li L, Zhao K, Lin Q, Li H, Xue X, Ge W, He H, Liu D, Xie H, et al. A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth. Cell Death Differ. 2020;27:1431–1446. doi: 10.1038/s41418-019-0449-8. - DOI - PMC - PubMed
    1. Guo Y, Xiao Z, Yang L, Gao Y, Zhu Q, Hu L, Huang D, Xu Q. Hypoxia-inducible factors in hepatocellular carcinoma (Review) Oncol Rep. 2020;43:3–15. - PMC - PubMed
    1. Méndez-Blanco C, Fernández-Palanca P, Fondevila F, González-Gallego J, Mauriz JL. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: A systematic review with meta-analysis. Ther Adv Med Oncol. 2021;13:1758835920987071. doi: 10.1177/1758835920987071. - DOI - PMC - PubMed